Organization
Air Force Medical University
1 abstract
Abstract
Efficacy and safety of recombinant humanized anti-HER2 antibody-MMAE conjugate (RC48) in neoadjuvant for HER2-positive breast cancer: A single-arm phase II study.Org: Air Force Medical University,